Empagliflozin attenuates neointimal hyperplasia after drug-eluting-stent implantation in patients with type 2 diabetes
Takehiro Hashikata, Masayasu Ikutomi, Takahiro Jimba, Akito Shindo, Nobutaka Kakuda, Susumu Katsushika, Masaaki Yokoyama, Mikio Kishi, Takahiro Sato, Masashiro Matsushita, Satoshi Ohnishi, Masao Yamasaki
Topics & Concepts
MedicineEmpagliflozinInternal medicineCardiologyNeointimal hyperplasiaType 2 diabetesDiabetes mellitusStentCoronary artery diseaseDrug-eluting stentSurgeryEndocrinologyRestenosisDiabetes Treatment and ManagementCoronary Interventions and DiagnosticsCardiovascular Function and Risk Factors